AMY RAINS: Open Payments
NPI 1801206859 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,499 in 130 payments from 22 companies in 2025. Trend: 2023 $14,487 · 2024 $10,009 · 2025 $6,499
Speaker / faculty: $4,104Food & beverage: $2,292Education: $103
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $4,735 |
| Teva Pharmaceuticals USA, Inc. | 26 | $674 |
| PFIZER INC. | 18 | $277 |
| Neurocrine BioSciences, Inc. | 12 | $208 |
| ACADIA Pharmaceuticals Inc | 5 | $104 |
| MDD US Operations, LLC | 5 | $92 |
| Lundbeck LLC | 3 | $65 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| HARMONY BIOSCIENCES LLC | 2 | $41 |
| TG Therapeutics, Inc. | 1 | $27 |
Products named: QULIPTA, UBRELVY, AUSTEDO XR, NURTEC ODT, BOTOX, INGREZZA, NUPLAZID, VYEPTI.
Industry payments across TN — which companies pay providers there.
